Oral anticoagulant therapy for patients with atrial fibrillation--an update.
Hylek
Elaine M
EM
Boston University School of Medicine, Department of Medicine, Boston, MA, USA. ehylek@bu.edu
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage*; D001281:Atrial Fibrillation / Q000097:blood / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D001794:Blood Pressure; D004359:Drug Therapy, Combination; D006801:Humans; D019934:International Normalized Ratio; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin